ADAM33 rs2280090: Understanding Asthma Susceptibility Associations
The rs2280090 variant is a single-nucleotide polymorphism located within the ADAM33 gene, which has been extensively studied for its potential role in asthma susceptibility. Research suggests that this variant, often as part of a larger haplotype, may influence bronchial hyperresponsiveness and airway remodeling in various populations.
What each genotype means
Typical asthma risk profile
This genotype represents the common variant at this position in the ADAM33 gene. Research suggests that individuals with this genotype do not carry the specific risk-associated allele linked to asthma susceptibility in certain populations. Please note that asthma is a complex condition influenced by many genetic and environmental factors, and this result should not be used to predict or rule out health outcomes.
This is the most common genotype in many global populations, though exact frequencies vary significantly by ancestry.
Intermediate asthma risk profile
Carrying one copy of the G allele may be associated with a different risk profile for asthma compared to those without it. Studies in some populations have observed that this variant, which is part of a larger haplotype in the ADAM33 gene, may influence susceptibility to bronchial hyperresponsiveness. Because genetic associations are often ancestry-specific and complex, you should discuss any respiratory concerns with your healthcare provider.
This heterozygous genotype is found at varying frequencies across different ethnic groups, reflecting the diverse genetic architecture of the ADAM33 gene.
Increased asthma risk profile
Research in specific populations, such as in West Bengal, India, has identified the GG genotype as having a significant statistical association with an increased risk for asthma. This variant is located in the cytoplasmic domain of the ADAM33 protein and is often found in high linkage disequilibrium with other asthma-associated markers. This association is not universal across all ancestries, and you should consult a clinician regarding any personal or family history of asthma.
The frequency of this genotype is variable and generally less common than the A-allele combinations in many populations.
What is rs2280090?
The rs2280090 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), situated within the ADAM33 gene on human chromosome 20. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ADAM33 gene is notable for being one of the first genes identified through positional cloning as a candidate for asthma susceptibility. Because genes are often inherited in blocks known as haplotypes, rs2280090 is frequently analyzed alongside other nearby SNPs in the same gene. Researchers look at these patterns to understand how specific variations might contribute to complex traits like asthma, which are influenced by both genetic and environmental factors. It is important to note that the presence of a specific SNP does not guarantee the development of a condition, as asthma is a polygenic disease involving many different genetic and lifestyle contributors.
The Role of the ADAM33 Gene
The ADAM33 gene encodes a protein called a disintegrin and metalloproteinase 33. This protein is primarily expressed in mesenchymal cells, such as smooth muscle cells and fibroblasts, which are critical components of the airway structure in the lungs. ADAM33 is believed to play a significant role in airway remodeling, a process where the structure of the airways changes in response to chronic inflammation, potentially leading to the narrowing and hyperresponsiveness characteristic of asthma. By facilitating the shedding of various cell-surface proteins, the ADAM33 protein may influence how cells communicate and interact within the lung tissue. While its exact biological mechanism in the context of asthma is still being investigated, its involvement in structural changes suggests it may contribute to the underlying susceptibility to respiratory conditions rather than just the inflammatory response itself.
Research and Evidence Strength
The evidence linking ADAM33 variants, including rs2280090, to asthma is considered moderate and highly context-dependent. Since its initial discovery, numerous studies have attempted to replicate the association between ADAM33 polymorphisms and asthma across different ethnic groups. While some studies have found significant associations with asthma, bronchial hyperresponsiveness, and elevated IgE levels, others have failed to replicate these findings in different populations. This inconsistency highlights the complexity of asthma genetics; the effect of a single SNP can vary significantly based on the genetic background of the population being studied. Furthermore, some researchers argue that the observed associations are more robust when looking at haplotypes—combinations of multiple SNPs—rather than individual variants like rs2280090 alone. Consequently, while ADAM33 remains a prominent candidate gene, the scientific community views these associations as complex and not universally applicable across all human ancestries.
Population Frequency and Variability
The frequency of the rs2280090 variant is variable across different global populations. Genetic studies have shown that the prevalence of specific alleles can differ significantly between groups, such as Caucasian, African American, Hispanic, and various Asian populations. This variability is a common feature of complex genetic traits and is one reason why association studies often yield different results depending on the cohort being analyzed. Because the frequency of the variant is not uniform, the potential impact of the SNP on asthma risk may also differ by ancestry. Researchers emphasize that these frequency differences are a natural part of human genetic diversity and underscore the importance of conducting diverse, large-scale genomic studies to fully understand how specific variants contribute to health outcomes across the global population.
Interpreting Your Genetic Information
If you have information about your rs2280090 genotype, it is important to interpret it within the context of current scientific understanding. This variant is associated with complex traits, meaning it is only one small piece of a much larger puzzle involving your environment, lifestyle, and thousands of other genetic factors. Having a specific genotype does not serve as a medical diagnosis for asthma or any other respiratory condition. If you have concerns about your lung health, breathing, or a family history of asthma, you should consult with a healthcare professional, such as a pulmonologist or an allergist. They can provide appropriate clinical evaluations, such as lung function tests, which are far more informative for your health than genetic data alone. Never use genetic information to make decisions about medications or treatments; always discuss your health status and any potential concerns directly with your clinician.
How common is this variant?
The frequency of the rs2280090 variant is highly variable across different ancestral populations, with no single frequency applicable to all groups.
Frequently asked questions
Does having the rs2280090 variant mean I have asthma?
No, having this variant does not mean you have asthma. Asthma is a complex condition influenced by many genetic and environmental factors, and this SNP is only one of many potential contributors.
Can I use this SNP to predict if my child will develop asthma?
Genetic testing for this SNP is not a diagnostic tool for asthma. Clinical diagnosis is based on symptoms and lung function tests performed by a medical professional.
Why do some studies say ADAM33 is linked to asthma and others do not?
Asthma is a complex, polygenic disease. Differences in study results often arise from the genetic diversity of the populations studied and the fact that multiple genes and environmental factors interact to influence asthma risk.
Should I change my medication based on my ADAM33 genotype?
No. You should never change your medication or treatment plan based on genetic information. Always consult your doctor or pharmacist before making any changes to your prescribed health regimen.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2280090?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADAM33
Intronic susceptibility variant in the metalloproteinase ADAM33 gene associated with allergic hyperresponsiveness and atopic airway remodeling.
Noncoding functional polymorphism in the asthma and allergy risk gene ADAM33 linked to altered bronchial reactivity and atopic susceptibility.
This variant is part of a haplotype associated with increased risk of asthma in patient populations.
This variant is part of a haplotype associated with increased risk of asthma in patient populations.
